Showing 301 - 320 results of 16,164 for search '(( significant increase decrease ) OR ( significant ((we decrease) OR (mean decrease)) ))', query time: 0.46s Refine Results
  1. 301

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
  2. 302

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
  3. 303
  4. 304
  5. 305
  6. 306

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Through combining meta-analysis and analytic hierarchy process (AHP) model, we demonstrated that, compared to virgin MNPs, aged MNPs would result in biomass decrease and oxidative stress increase on organisms and lead to total N/P decrease and greenhouse gas emissions increase on ecosystems while causing cell apoptosis, antioxidant system reaction, and inflammation in human health. …”
  7. 307

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Through combining meta-analysis and analytic hierarchy process (AHP) model, we demonstrated that, compared to virgin MNPs, aged MNPs would result in biomass decrease and oxidative stress increase on organisms and lead to total N/P decrease and greenhouse gas emissions increase on ecosystems while causing cell apoptosis, antioxidant system reaction, and inflammation in human health. …”
  8. 308
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  16. 316

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  17. 317

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  18. 318

    S1 Data - by Miki Doi (15347878)

    Published 2024
    Subjects:
  19. 319
  20. 320